Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies

Alan H. Beggs, Eric P. Hoffman, Judith R. Snyder, Kiichi Arahata, Linda Specht, Frederic Shapiro, Corrado Angelini, Hideo Sugita, Louis M. Kunkel

Research output: Contribution to journalArticle

309 Citations (Scopus)

Abstract

Becker muscular dystrophy (BMD) often results from in-frame mutations of the dystrophin gene that allow production of an altered but partially functional protein. To address potential structure-function relationships for the various domains of dystrophin, we examined both the dystrophin gene and protein in 68 patients with abnormal dystrophin. Eighty-six percent of BMD patients with dystrophin of altered size have deletions or duplications, and the observed sizes of dystrophin fit well with predictions based on DNA data. Deletions within the amino-terminal domain I tended to result in low levels of dystrophin and a more severe phenotype. The phenotypes of patients with deletions or duplications in the central rod domain were more variable. This region can be divided into three portions based on differences in clinical presentations of patients. Deletions around exons 4553 were most common and generally caused typical BMD; however, phenotypic variability among patients with similar mutations suggests that epigenetic and/or environmental factors play an important role in determining the clinical progression. In contrast, deletions or duplications in the proximal portion of this domain tended to cause severe cramps and myalgia. Finally, loss of the middle of this region probably causes a very mild phenotype, as only one such patient was found and his only symptom was elevated serum creatine phosphokinase levels.

Original languageEnglish
Pages (from-to)54-67
Number of pages14
JournalAmerican Journal of Human Genetics
Volume49
Issue number1
Publication statusPublished - Jul 1991

Fingerprint

Dystrophin
Duchenne Muscular Dystrophy
Proteins
Phenotype
Muscle Cramp
Mutation
Myalgia
Creatine Kinase
Epigenomics
Exons
DNA
Serum
Genes

ASJC Scopus subject areas

  • Genetics

Cite this

Beggs, A. H., Hoffman, E. P., Snyder, J. R., Arahata, K., Specht, L., Shapiro, F., ... Kunkel, L. M. (1991). Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies. American Journal of Human Genetics, 49(1), 54-67.

Exploring the molecular basis for variability among patients with Becker muscular dystrophy : Dystrophin gene and protein studies. / Beggs, Alan H.; Hoffman, Eric P.; Snyder, Judith R.; Arahata, Kiichi; Specht, Linda; Shapiro, Frederic; Angelini, Corrado; Sugita, Hideo; Kunkel, Louis M.

In: American Journal of Human Genetics, Vol. 49, No. 1, 07.1991, p. 54-67.

Research output: Contribution to journalArticle

Beggs, AH, Hoffman, EP, Snyder, JR, Arahata, K, Specht, L, Shapiro, F, Angelini, C, Sugita, H & Kunkel, LM 1991, 'Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies', American Journal of Human Genetics, vol. 49, no. 1, pp. 54-67.
Beggs, Alan H. ; Hoffman, Eric P. ; Snyder, Judith R. ; Arahata, Kiichi ; Specht, Linda ; Shapiro, Frederic ; Angelini, Corrado ; Sugita, Hideo ; Kunkel, Louis M. / Exploring the molecular basis for variability among patients with Becker muscular dystrophy : Dystrophin gene and protein studies. In: American Journal of Human Genetics. 1991 ; Vol. 49, No. 1. pp. 54-67.
@article{668360d2805c400bb4a1c124a193f723,
title = "Exploring the molecular basis for variability among patients with Becker muscular dystrophy: Dystrophin gene and protein studies",
abstract = "Becker muscular dystrophy (BMD) often results from in-frame mutations of the dystrophin gene that allow production of an altered but partially functional protein. To address potential structure-function relationships for the various domains of dystrophin, we examined both the dystrophin gene and protein in 68 patients with abnormal dystrophin. Eighty-six percent of BMD patients with dystrophin of altered size have deletions or duplications, and the observed sizes of dystrophin fit well with predictions based on DNA data. Deletions within the amino-terminal domain I tended to result in low levels of dystrophin and a more severe phenotype. The phenotypes of patients with deletions or duplications in the central rod domain were more variable. This region can be divided into three portions based on differences in clinical presentations of patients. Deletions around exons 4553 were most common and generally caused typical BMD; however, phenotypic variability among patients with similar mutations suggests that epigenetic and/or environmental factors play an important role in determining the clinical progression. In contrast, deletions or duplications in the proximal portion of this domain tended to cause severe cramps and myalgia. Finally, loss of the middle of this region probably causes a very mild phenotype, as only one such patient was found and his only symptom was elevated serum creatine phosphokinase levels.",
author = "Beggs, {Alan H.} and Hoffman, {Eric P.} and Snyder, {Judith R.} and Kiichi Arahata and Linda Specht and Frederic Shapiro and Corrado Angelini and Hideo Sugita and Kunkel, {Louis M.}",
year = "1991",
month = "7",
language = "English",
volume = "49",
pages = "54--67",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Exploring the molecular basis for variability among patients with Becker muscular dystrophy

T2 - Dystrophin gene and protein studies

AU - Beggs, Alan H.

AU - Hoffman, Eric P.

AU - Snyder, Judith R.

AU - Arahata, Kiichi

AU - Specht, Linda

AU - Shapiro, Frederic

AU - Angelini, Corrado

AU - Sugita, Hideo

AU - Kunkel, Louis M.

PY - 1991/7

Y1 - 1991/7

N2 - Becker muscular dystrophy (BMD) often results from in-frame mutations of the dystrophin gene that allow production of an altered but partially functional protein. To address potential structure-function relationships for the various domains of dystrophin, we examined both the dystrophin gene and protein in 68 patients with abnormal dystrophin. Eighty-six percent of BMD patients with dystrophin of altered size have deletions or duplications, and the observed sizes of dystrophin fit well with predictions based on DNA data. Deletions within the amino-terminal domain I tended to result in low levels of dystrophin and a more severe phenotype. The phenotypes of patients with deletions or duplications in the central rod domain were more variable. This region can be divided into three portions based on differences in clinical presentations of patients. Deletions around exons 4553 were most common and generally caused typical BMD; however, phenotypic variability among patients with similar mutations suggests that epigenetic and/or environmental factors play an important role in determining the clinical progression. In contrast, deletions or duplications in the proximal portion of this domain tended to cause severe cramps and myalgia. Finally, loss of the middle of this region probably causes a very mild phenotype, as only one such patient was found and his only symptom was elevated serum creatine phosphokinase levels.

AB - Becker muscular dystrophy (BMD) often results from in-frame mutations of the dystrophin gene that allow production of an altered but partially functional protein. To address potential structure-function relationships for the various domains of dystrophin, we examined both the dystrophin gene and protein in 68 patients with abnormal dystrophin. Eighty-six percent of BMD patients with dystrophin of altered size have deletions or duplications, and the observed sizes of dystrophin fit well with predictions based on DNA data. Deletions within the amino-terminal domain I tended to result in low levels of dystrophin and a more severe phenotype. The phenotypes of patients with deletions or duplications in the central rod domain were more variable. This region can be divided into three portions based on differences in clinical presentations of patients. Deletions around exons 4553 were most common and generally caused typical BMD; however, phenotypic variability among patients with similar mutations suggests that epigenetic and/or environmental factors play an important role in determining the clinical progression. In contrast, deletions or duplications in the proximal portion of this domain tended to cause severe cramps and myalgia. Finally, loss of the middle of this region probably causes a very mild phenotype, as only one such patient was found and his only symptom was elevated serum creatine phosphokinase levels.

UR - http://www.scopus.com/inward/record.url?scp=0025745162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025745162&partnerID=8YFLogxK

M3 - Article

C2 - 2063877

AN - SCOPUS:0025745162

VL - 49

SP - 54

EP - 67

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -